Background: FDG-PET/CT is part of the standard diagnostic management of a patients with a large variety of common and less common malignant tumors, based on the increased glucose metabolism within tumors.Case presentation: A hybrid fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) was performed in a neurofibromatosis patient to rule out relapse of malignant peripheral nerve sheet tumor. The scan revealed non-malignant neurofibromas, a testis seminoma and hypermetabolic syphilitic granulomata.Conclusion: This case stresses the need to rule out infectious diseases when atypical hypermetabolic lesions are present. © 2014 Patrick et al.; licensee BioMed Central Ltd.
CITATION STYLE
Schöffski, P., Deroose, C. M., Gheysens, O., Lips, N., Slabbaert, K., Vancleynenbreugel, B., … Peetermans, W. E. (2014). The more you look, the more you find: Challenging results on FDG-PET CT in a patient with neurofibromatosis type I. BMC Medical Imaging, 14(1). https://doi.org/10.1186/1471-2342-14-19
Mendeley helps you to discover research relevant for your work.